Hallmarks of metastasis

Lung Cancer Metastasis: Novel Biological Mechanisms and Impact on Clinical Practice

Volumn , Issue , 2009, Pages 29-46

  Ray, M Roshni ^a   Jablons, David M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84900625733     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-0772-1_2     Document Type: Chapter

References (57)

1. Cairns, J. Mutation selection and the natural history of cancer. Nature 255: 187-200, 1975.
2. Weigelt, B., Peterse, J.L., and van 't Veer, L.J. Breast cancer metastasis: markers and models. Nature Rev Cancer 5: 591-602, 2005.
3. Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., and Thun, M.J. Cancer statistics. Ca Cancer J Clin 58: 71-96, 2008.
4. Wang, W., Goswami, S., Lapidus, K., Wells, A.L., Wyckoff, J.B., Sahai, E., Singer, R.H., Segall, J.E., and Condeelis, J.S. Identification and testing of gene expression signature of invasive carcinoma cells within primary mammary tumors. Cancer Res 64: 8585-8594, 2004.
5. Leemans, C.R., Tiwari, R., Nauta, J.J., van der Waal, I., and Snow, G.B. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer Res 71: 452-456, 1993.
6. Braun, S., Pantel, K., Mueller, P., Janni, W., Hepp, F., Kentenich, C.R.M., Gastroph, S., Wischnik, A., Dimpfl, T., Kindermann, G., Riethmueller, G., and Schlimok, G. Cytoker-atin-positive bone marrow micrometastases an survival of breast cancer patients with stage I-III disease. N Engl J Med 342: 525-533, 2000.
7. Mehlen, P. and Puisieux, A. Metastasis: a question of life or death. Nature Rev Cancer 6: 449-458, 2006.
8. Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caliguri, M.A., and Dick, J.E. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature 17: 645-648, 1994.
9. Singh, S.K., Clarke, I.D., Terasaki, M., Bonn, V.E., Hawkins, C., Squire, J., and Dirks, P.B. Identification of a cancer stem cell in human brain tumours. Cancer Res 63: 5821-5828, 2003.
10. Krystal, G.W., Hines, S.J., and Organ, C.P. Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor. Cancer Res 56: 370-376, 1996.
11. Kim, C.F., Jackson, E.L., Woolfenden, A.E., Lawrence, S., Babar, I., Vogel, S., Crowley, D., Bronson, R.T., and Jacks, T. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121: 823-835, 2005.
12. Klein, W.M., Wu, B.P., Zhao, S., Wu, H., Klein-Szanto, A.J.P., and Tahan, S.R. Increased expression of stem cell markers in malignant melanoma. Modern Pathol 20: 102-107, 2007.
13. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 100: 3983-3988, 2003.
14. Pardal, R., Clarke, M.F., and Morrison, S.J. Applying the principles of stem cell biology to cancer. Nature Rev Cancer 3: 895-902, 2003.
15. Kucia, M., Reca, R., Miekus, K., Wanzeck, J., Wojakowski, W., Janowska-Wieczorek, A., Ratajczak, J., and Ratajczak, M.Z. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis. Stem Cells 23: 879-894, 2005.
16. Oft, M., Akhurst, R.J., and Balmain, A. Metastasis is driven by sequential elevation of H-ras and Smad2 levels. Nature Cell Biol. 4: 487-494, 2002.
17. Sahai, E. Mechanisms of cancer cell invasion. Curr Opin Gen Dev 15: 87-96, 2005.
18. Ozanne, B.W., McGarry, L., Spence, H.J., Johnston, I., Winnie, J., Meagher, L., and Stapleton, G. Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme. Eur J Cancer 36: 1640-1648, 2000.
19. Eccles, S.A. and Welch, D.R. Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757, 2007.
20. Martin, S.S. and Leder, P. Human MCF10A mammary epithelial cells undergo apoptosis following actin depolymerization that is independent of attachment and rescued by Bcl-2. Mol. Cell Biol 21: 6529-6536, 2001.
21. Pinkas, J., Martin, S. S., and Leder, P. Bcl-2-mediated cell survival promotes metastasis of EpH4 bMEKDD mammary epithelial cells. Mol Cancer Res 2: 551-556, 2004.
22. Mazieres, J., He, B., You, L., Xu, Z., and Jablons, D.M. Wnt signaling in lung cancer. Cancer Lett 222: 1-10, 2005.
23. You, L., Kim, J., He, B., Xu, Z., McCormick, F., and Jablons, D.M. Wnt-1 signal as a potential cancer therapeutic target. Drug News Perspectives 19: 1-5, 2006.
24. Wolf, K., Mazo, I., Leung, H., Engelke, K., von Andrian, U.H., Deryugina, E.I., Strongin, A.Y., Brocker, E.B., and Friedl, P. Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 160: 267-277, 2003.
25. Pollard, T.D. and Borisy, G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 112: 453-465, 2003.
26. Wang, H.R., Ogunjimi, A.A., Zhang, Y., Ozdamar, B., Bose, R., and Wrana, J.L. Degradationof RhoA bySmurf1 Ubiquitin ligase. Methods Enzymol 406: 437-447, 2006.
27. Wyckoff, J.B., Pinner, S.E., Gschmeissner, S., Condeelis, J.S., and Sahai, E. ROCK-and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion. In Vivo Curr Biol 16: 1515-1523, 2006.
28. Sahai, E. and Marshall, C.J. Differing modes of tumour cell invasion have distinct requirements for Rho/ROCK signaling and extracellular proteolysis. Nature Cell Biol 5: 711-720, 2003.
29. Wyckoff, J.B., Jones, J.G., Condeelis, J.S., and Segall, J.E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Res 60: 2504-2511, 2000.
30. Pantel, K., Brakenhoff, R. H., and Brandt, B. Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer 8: 329-340, 2008.
31. Steeg, P.S. Tumor metastasis: mechanistic insights and clinical challenges. Nat Med 12: 895-904, 2006.
32. Burnet, F.M. The concept of immunological surveillance. Prog Exp Tumor Res 13: 1-27, 1970.
33. Thomas, L. Onimmunosurveillance in human cancer. Yale J Biol Med 55: 329-333, 1982.
34. Bradbury, P.A. and Shepherd, F.A. Immunotherapy for lung cancer. J Thoracic Oncol 3: S164-S170, 2008.
35. Pardoll, D. Does the immune system see tumors asforeign orself? Annu Rev Immunol 21: 807-839, 2003.
36. Wood, S.J. Pathogenesis of metastasis formation observed in vivo in the rabbit ear chamber. AMA Arch Pathol 66: 550-568, 1958.
37. Fidler, I.J. Metastasis: quantitative analysis of distribution and fate of tumor embolila-beled with 125 I-5-iodo-2'-deoxyuridine. J Natl Cancer Inst 45: 773-782, 1970.
38. Fidler, I.J. and Nicolson, G.L. Fate of recirculating B16 melanoma metastatic variant cells in parabiotic syngeneic recipients. J Natl Cancer Inst 58: 1867-1872, 1977.
39. Paget, S. The distribution of secondary growths in cancer of the breast. Lancet 1: 571-573, 1889.
40. Yu, Q., Toole, B.P. and Stamenkovic, I. Induction of apoptosis of metastatic mammary carcinoma cells invivoby disruptionoftumor cell surface CD44 function. JExp Med 186: 1985-1996, 1997.
41. Perou, C.M., Sørlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J. R., Ross, D.T., Johnsen, H., Akslen, L.A., Fluge, Ø., Pergamenschikov, A., Williams, C., Zhu, S.X., Lønning, P.E., Børresen-Dale, A.L., Brown, P.O., and Botstein, D. Molecular portraits of human breast tumours. Nature 406: 747-752, 2000.
42. Ramaswamy, S., Ross, K.N., Lander, E.S., and Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nature Genetics 33: 49-54, 2002.
43. Welch, D.R., Steeg, P.S., and Rinker-Schaeffer, C.W. Molecular biology of breast metastasis: Genetic regulation of human breast carcinoma metastasis. Breast Cancer Res 2: 408-416, 2002.
44. Steeg, P.S. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 3: 55-63, 2003.
45. Ohtaki, T., Shintani, Y., Honda, S., Matsumoto, H., Hori, A., Kanehashi, K., Terao, Y., Kumano, S., Takatsu, Y., Masuda, Y., Ishibashi, Y., Watanabe, T., Asada, M., Yamada, T., Suenaga, M., Kitada, C., Usuki, S., Kurokawa, T., Onda, H., Nishimura, O., Fujino, M. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature 411: 613-617, 2001.
46. Sahai, E. Illuminating the metastatic process. Nature Rev Cancer 7: 737-749, 2007.
47. Goodale, D., Phay, C., Postenka, C.O., Keeney, M., and Allan, A.L. Characterization of tumor cell dissemination patterns in preclinical models of cancer metastasis using flow cytometry and laser scanning cytometry. Cytometry Part A 9999: NA, 2008.
48. Sipkins, D.A., Wei, X., Wu, J.W., Runnels, J.M., Cote, D., Means, T.K., Luster, A.D., Scadden, D.T., Lin, C.P. In vivo imaging of specialized bone marrow endothelial micro-domains for tumour engraftment. Nature 435: 969-973, 2005.
49. Kim, J.W., Wong, C.W., Glodsmith, J.D., Song, C., Fu, W., Allion, M.B., Herlyn, M., Al-Mehdi, A.B., and Muschel, R.J. Rapid apoptosis in the pulmonary vasculature distinguishes non-metastatic from metastatic melanoma cells. Cancer Lett 213: 203-212, 2004.
50. Jordan, C.T., Guzman, M. L., and Noble, M. Cancer stem cells. New England J Med 355: 1253-1261, 2006.
51. Pantel, K. and Brakenhoff, R.H. Dissecting the metastatic cascade. Nature Rev Cancer 4: 448-456, 2004.
52. Goldhirsch, A., Wood, W. C., Gelber, R. D., Coates, A. S., Thuerlimann, B., and Senn, H. J. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 21: 3357-3365, 2003.
53. Raz, D.J., Ray, M.R., Kim, J.Y., He, B., Taron, M., Skrzypski, M., Segal, M., Gandara, D.R., Rosell, R., and Jablons, D.M. A multigene assay is prognostic of survival in patients with early-stage lung adenocarcinoma. Clin Cancer Res. 14: 5565-5570, 2008.
54. Overall, C.M., and Lopez-Otin, C. Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat Rev Cancer 2: 657-672, 2002.
55. Folkman, J. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. N Engl J Med 333: 1757-1763, 1995.
56. Pander, J., Gelderblom, H., and Guchelaar, H.J. Pharmacogenetics of EGFR and VEGF inhibition. Drug Discovery Today 12: 1054-1060, 2007.
57. Thatcher, N. First-and second-line treatment of advanced metastatic non-small-cell lung cancer: a global view. BMC Proc. 2: S3, 2008.